Pharmafile Logo

From promise to practice: immuno-oncology in action Part 3 – Emerging Markets

Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.


This is the final part in the series where we interviewed key opinion leader physicians and payers to explore how new oncology products are likely to fare clinically and financially. In Part 1 we looked at the current situation in the US and in part 2 we explored how the situation is developing in the EU. 

Download parts 1, 2 and 3: http://www.researchpartnership.com/news/2015/11/free-thinking-from-promise-to-practice-immuno-oncolo…

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market

From chaos to calm: how to make sense of social media

What do you know about chaos theory?

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

Infographic: HCV LATAM

An introduction to the HCV LATAM patient.

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard